Articles tagged with Covid 19 Vaccines
Researchers at La Jolla Institute for Immunology have developed six lines of humanized mice to study human cases of COVID-19, shedding light on SARS-CoV-2's movement through the body and varying symptoms. The models help understand how different genetic backgrounds influence disease progression.
A nationwide Swedish study found that full vaccination significantly reduced the risk of severe cardiovascular outcomes linked to COVID-19, such as heart attack and stroke. However, temporary increases in cardiovascular risk were observed after individual doses, particularly among elderly and males.
A multinational study found that people with unmedicated mental illness are less likely to be vaccinated against COVID-19, with a 9% lower vaccination rate compared to the general population. Individuals with substance use disorder were also 16% less likely to receive the vaccine.
A new poll from Michigan Medicine shows that nearly half of people age 50 and older plan to get the updated COVID-19 vaccine. However, some older adults with high risk of severe illness appear unlikely to seek the vaccine, highlighting the need for increased encouragement from clinicians and other sources.
Researchers at Boston University discovered a new method to harness self-amplifying RNA to create more effective vaccines. The modified saRNA vaccine protected mice from severe COVID-19 disease with a lower dose than current mRNA vaccines. Longer duration of protein expression and reduced inflammation were also observed.
The Advisory Committee on Immunization Practices (ACIP) has been instrumental in responding to the COVID-19 pandemic by providing transparent decision-making and prioritizing equitable access to vaccines. The committee's virtual meetings enabled timely discussions and evidence review, allowing for rapid approval of COVID-19 vaccines. H...
A new study published in Microorganisms highlights the importance of small molecule drugs that target the unchanging parts of the SARS-CoV-2 virus. The research suggests that these stable targets could provide a consistent and reliable treatment option for COVID-19, even as vaccines are updated to address changing viral strains.
Researchers developed artificial lymphoid organ-chips to recreate human immune system's response to booster vaccines. The technology could potentially be used to evaluate the likely effectiveness of new protein and mRNA-based booster vaccines for COVID-19 and other infectious diseases.
Researchers found stress, BMI, exercise, and hormonal birth control use contribute to varying experiences of post-vaccine symptoms. Women reported higher levels of stress and less regular exercise than men, while those on hormonal birth control experienced more side effects.
Researchers at UT Austin have developed a broadly neutralizing plasma antibody called SC27 that can neutralize all known COVID-19 variants. This discovery was made possible by the technology of Ig-Seq, which provides a closer look at the antibody response to infection and vaccination.
A new study from Tulane University found that state-level COVID-19 vaccination mandates increased vaccine rates among health care workers by 3-4%, with improvements seen in states that required vaccinations without opt-outs. The policy was particularly effective among health care workers between the ages of 25-49 years.
Scientists have discovered that immune cells migrate to the nasal conchae after vaccination or infection, secreting antibodies locally into the nasal cavity. This finding could lead to more effective nasal vaccinations and new treatments for autoimmune diseases.
Researchers in China used a scenario experiment to test messaging strategies on COVID-19 vaccine uptake. The study found that emphasizing personal risk rather than personal gain or community benefits was most effective in persuading people to get vaccinated.
Patients with post-COVID-19 mRNA vaccination myocarditis show lower cardiovascular complications at 18 months compared to those with conventional myocarditis. However, affected patients may require medical management for several months after hospital discharge.
A next-generation COVID-19 vaccine has been developed using a live attenuated intranasal approach, inducing strong memory responses and long-term protection. The vaccine provides cross-protection against all variants of concern and is highly effective against major SARS-CoV-2 proteins.
A new study of 18 million people reveals a higher incidence of mental illnesses for up to a year following severe COVID-19, particularly in unvaccinated individuals. Vaccination appeared to mitigate the negative effects of COVID-19 on mental health.
A cohort study found elevated depression and anxiety levels in unvaccinated people with COVID-19 diagnosis compared to before or without the virus. Vaccination was associated with lower incidence of mental illnesses after hospitalization for COVID-19.
A new study published in Neurology found that COVID-19 vaccination does not increase the risk of relapse in people with multiple sclerosis. However, participants with high MS activity and those who received booster doses did show a small increased risk, especially if they were not taking disease-modifying treatments.
A recent study found that US state COVID-19 vaccine mandates for healthcare workers led to increased vaccine uptake, particularly among younger workers and those in states without a test-out option. The findings suggest that vaccine mandates can further promote vaccination in already highly vaccinated healthcare populations.
A new study published in PLOS Computational Biology found that prioritizing older individuals for booster vaccination consistently leads to the best public health outcomes, regardless of economic level or age category. This strategy is more effective than vaccinating younger individuals with the most contacts.
Researchers at Stanford University developed a nanoparticle platform to make vaccines more effective against various pathogens. The platform allows for the elicitation of different immune responses, enabling the identification of the most effective type of protection.
Researchers at the University of Houston have developed two nasal sprays, NanoSTING and NanoSTING-SN, to prevent respiratory virus transmission. NanoSTING is an immune activator that can protect against multiple viruses, while NanoSTING-SN is a pan-coronavirus vaccine that can prevent transmission to unvaccinated individuals.
A recent study found that behavioral nudges in social media ads had limited ability to encourage COVID-19 vaccination across countries. Nudge ads with messages appealing to norms and family/ community protection performed better than placebo ads, but only in certain contexts.
A Spanish research study has described the composition of the immune system in blood samples from patients with multiple myeloma and found that altered immune cells influence vaccine efficacy. The study reveals a more severe immune suppression in patients with multiple myeloma compared to those with other tumors.
A comprehensive meta-analysis found that interventions increasing access to vaccines and providing transportation assistance tripled vaccination odds, particularly in low-income countries. Financial incentives also showed a moderate effect, but were less impactful.
A 50-state survey of US adults reveals decreased trust in physicians and hospitals during the COVID-19 pandemic. Lower levels of trust were associated with a lesser likelihood of pursuing vaccination, highlighting the importance of restoring public trust in healthcare.
Researchers at WashU Medicine developed a nasal COVID-19 vaccine that halted transmission in hamsters, showing promise for controlling respiratory infections. The vaccine targeted the virus's entry points in the nose and mouth, reducing viral replication and preventing spread.
A new study analyzing health records from 46 million adults in England found that COVID-19 vaccination significantly reduces the incidence of heart attacks and strokes. The incidence was up to 10% lower after the first dose and up to 27% lower after two doses, especially with the AstraZeneca vaccine.
A new study has found that 90-95% of participants produced strong T-cell responses after exposure to adenoviral vaccines in a lab setting. This unexpected finding may have implications for the effectiveness and safety of future COVID-19 vaccines, as well as other infectious diseases.
The risk of developing long COVID has decreased significantly over time, primarily attributed to vaccination against COVID-19. Despite this decline, the researchers found that vaccinated individuals still face a substantial risk of long COVID, with an estimated 3.5% rate in some groups.
A new approach in vaccine research, adaptive platform trials (APTs), offers a flexible adjustment of study design during ongoing clinical trials. This allows for quick adaptation to new developments and enables the recruitment of large numbers of participants across different countries.
A large Nordic registry-based study found no association between covid-19 infection or vaccination during the first trimester and major birth defects. The study included over 343,000 infants and adjusted for various factors, providing greater confidence in its conclusions.
A follow-up study found that COVID-19 infection accelerated the progression from pre-symptomatic to clinical type 1 diabetes in youth, with no observed effect in adults. Further research is needed to determine whether vaccination and monitoring for COVID-19 symptoms can help prevent or delay this progression.
Researchers analyzed genomic data and human travel patterns to understand the spread and evolution of Streptococcus pneumoniae. The study found that a pneumococcal vaccine reduced antibiotic resistance but allowed non-targeted strains to gain a competitive advantage, suggesting short-lived protection.
A study published by Nemours Children's Health and Endeavor Health found that states with high COVID-19 vaccination rates saw a significant decrease in pediatric asthma symptoms, with the largest decline seen in the highest quarter of vaccination rates.
Researchers discovered a correlation between higher COVID-19 vaccination rates and lower symptomatic child asthma prevalence. The study suggests that COVID-19 vaccination may provide protection against other human coronaviruses through cross-reactive antibody responses.
A study published in Clinical Infectious Diseases found that regular booster doses of bivalent vaccines can maintain a person's ability to neutralize multiple SARS-CoV-2 strains, including XBB.1.5. This is especially important for immunocompromised groups, such as solid organ transplant recipients.
The NIH is sponsoring a Phase 1 trial of an experimental nasal COVID-19 vaccine that may offer enhanced protection against emerging variants. The trial will enroll 60 adult participants and assess the safety and immune response of the vaccine candidate, MPV/S-2P.
A recent study investigated COVID-19 vaccine exposure in the first trimester and its potential impact on major structural birth defects. The results indicate that mRNA COVID-19 vaccine exposure during this period is not associated with an increased risk for selected birth defects among live births.
A recent study found that vaccination can reduce cognitive symptoms, including memory loss, after SARS-CoV-2 infection. Researchers identified IL-1β as a potential mechanism driving cognitive impairment and showed that prior vaccination reduced inflammation and lowered levels of this cytokine protein.
Researchers from the University of Pennsylvania found that sending well-designed reminder messages increased COVID-19 booster uptake by 21% on average, outperforming free round-trip Lyft rides. The most effective messages were those encouraging recipients to make a vaccination plan and highlighting high local transmission rates.
The Pfizer-BioNTech vaccine demonstrated strong protection against a range of COVID-19 outcomes, including hospital admission. Annual updates to the vaccine are recommended due to waning immunity from older versions.
A cohort study found that cannabis use was an independent risk factor for COVID-19-related complications, even after considering other risk factors. The study suggests that cannabis may increase the risk of severe illness and hospitalization due to COVID-19.
Researchers analyzed data from over 184,000 cancer patients to assess COVID-19 vaccine effectiveness. The study found that vaccination significantly reduces mortality and serious complications among cancer patients, especially those who received the booster dose.
Researchers used single-cell sequencing technology to study immune responses in healthy adult volunteers exposed to SARS-CoV-2. They discovered unique immune responses associated with resisting sustained viral infection and disease, including activation of specialized mucosal immune cells and a reduction in inflammatory white blood cells.
A cohort study found that more than 1 in 5 adults did not recover within 3 months of SARS-CoV-2 infection. The risk of recovery was lower among women and those with preexisting cardiovascular disease, but higher among vaccinated individuals during the Omicron variant wave.
A global meta-analysis of 1.8m women found COVID-19 vaccination reduces the risk of infection during pregnancy by 61% and hospitalization by 94%. Vaccination also lowers caesarean section risk by 9%, hypertensive disorders in pregnancy by 12%, and intensive care unit admission for newborns by 8%.
A new study found that at-home antibody tests can accurately identify individuals with inadequate immunity to COVID-19, shedding light on the need for booster vaccinations. The test's results may help high-risk populations make informed decisions about their health.
A new study led by UCSF found that COVID-19 vaccine side effects like headache and tiredness indicate a strong immune response. Those with more symptoms had nearly double the antibody levels of those without, suggesting the vaccine is effective in preventing infection.
A laboratory study found that passive heat exposure stresses the heart, increasing myocardial blood flow in all participants, regardless of age or health status. Adults with a history of CAD are at particular risk and may benefit from minimizing cardiac strain during extreme heat by staying cool.
A new study analyzed over 14,600 scientific publications funded by more than $4 billion in NIH grants, revealing key research topics such as clinical trials, vaccine distribution, and virology. The findings suggest that half of the funding went to five states: North Carolina, Washington, New York, California, and Massachusetts.
A 15-day course of nirmatrelvir-ritonavir did not demonstrate a significant improvement in select postacute sequelae of SARS-CoV-2 infection symptoms in vaccinated adults with prolonged symptom duration. Further studies are needed to determine the role of antivirals in PASC treatment.
A new Yale study published in Obstetrics & Gynecology found no link between COVID-19 vaccination during pregnancy and stillbirth outcomes. The research analyzed hundreds of records from the CDC's Vaccine Safety Datalink, comparing receipt of the vaccine to stillbirths versus live births.
A new commentary urges public health researchers to incorporate questions about partisan identity in demographic data collection, arguing that excluding this information could lead to ineffective policy and health promotion interventions. By including partisanship in more public health surveys, researchers can better track its impact o...
Research by APPC scholars found that increased knowledge about Covid-19 vaccination made a significant difference in reducing the disparity between Black and White Americans' vaccination rates. This increase was associated with improved trust in vaccine safety and efficacy, as well as reduced skepticism towards vaccines.
Patients who received COVID-19 vaccines after acute coronary syndromes had similar rates of primary composite end point and major adverse cardiovascular events (MACE) compared to unvaccinated patients. Retrospective studies have shown a short-term reduction in MACE risk after COVID-19 vaccination.
A new study by MIT Sloan researchers found that misleading content from mainstream sources, rather than outright misinformation, was the primary driver of vaccine hesitancy on Facebook. This type of content was seen much more widely and generated more skepticism about COVID-19 vaccines.
A new study by the Colorado School of Public Health found that high ICU occupancy levels during COVID-19 patients' stays contributed to increased mortality rates. The research highlights the critical need for tools to anticipate surges and effective resource management in healthcare systems.
New research shows updated COVID-19 vaccines still offer reasonably durable protection against infection, hospitalization, and death from COVID-19, but effectiveness decreases over time. Boosters targeting omicron subvariants are less protective against the now-dominant JN.1 strain.
Researchers at La Jolla Institute for Immunology found that people who experienced breakthrough COVID-19 infections develop T cells better equipped to recognize and target SARS-CoV-2. The study also discovered that B cells produce more diverse antibodies targeting common epitopes between the vaccine and variants.